Protective Effects of Konjac and Inulin Extracts on Type 1 and Type 2 Diabetes

Figure 6

Body weight was monitored over 6 weeks after starting treatments of konjac, inulin, or KI composition in db/db mice or wild-type controls (a). 6-week area under curve (b) for each group (increased over the wild-type group) and changes of the body weight (% increase or decrease from the baseline value at week 0) for each group at each week (c) were also analyzed. mice; data were presented as . , the konjac-, inulin- or KI-treated groups were compared with the db/db group using Bonferroni’s multiple comparisons test following two-way ANOVA with repeated measures (a). ^#, posttreatment thresholds were compared with pretreatment baselines at week 0 using Dunnett’s multiple comparisons test following two-way ANOVA with repeated measures (a). For (b) and (c), , the konjac-, inulin-, or KI-treated groups were compared with the wild-type or db/db groups, and ^#, the KI-treated group was compared with the konjac- or inulin-treated groups using Bonferroni’s multiple comparisons test following one-way ANOVA (b) or two-way ANOVA with repeated measures (c). Symbols were represented by the respective group colors that are significantly different from the comparing group.

(a)

(b)

(c)